Oxyntomodulin and Glicentin May Predict the Effect of Bariatric Surgery on Food Preferences and Weight Loss
Open accessThe DOI matches its Crossref record; 56 of the 58 references it cites were found in a registry or an index.
Abstract
Background: Alterations in several gastrointestinal hormones are implicated in the postoperative suppression of food intake leading to weight loss after Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG). The aim was to evaluate changes in responses of gastrointestinal hormones after RYGB and SG and the associations of these changes with weight loss, energy intake, and food preferences. Methods: Forty-two subjects with severe obesity were included (32 RYGB; 10 SG). Postprandial responses of glicentin, oxyntomodulin, glucagon-like peptide-1 (GLP-1), peptide YY (PYY), and ghrelin were measured before and 6 months after surgery. Energy intake and energy density were assessed before and 6 months after surgery using a buffet meal test and weight loss was assessed 18 months after surgery. Results: Postprandial concentrations of glicentin, oxyntomodulin, GLP-1, and ghrelin differed between RYGB and SG (all P ≤ .02). Enhanced responses of glicentin and oxyntomodulin predicted a greater weight loss (both P < .01) and were associated with a larger decrease in energy density (P ≤ .04). No associations were found for GLP-1, PYY, and ghrelin, and changes were not associated with changes in energy intake. When combing all hormones, 60%, 19%, and 33% of the variations in weight loss, energy intake, and energy density, respectively, could be explained. Conclusion: Postprandial responses of gastrointestinal hormones differed between RYGB and SG. Enhanced responses of glicentin and oxyntomodulin predicted a better weight loss and were associated with a decreased preference for energy-dense foods. Replication of these results could imply an opportunity to identify patients in need of additional support after surgical treatments of obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Looking for the next step in obesity pharmacotherapies, the concept of combining entero-pancreatic hormones for obesity treatment was supported by the marked WL, sustained weight maintenance, and metabolic benefits observed with BS, which increase multiple gut hormone levels [9–14].”
From Triple Agonism Based Therapies for Obesity (2025) · cites this paper as [12]
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
MacKinnon, D. P., Fairchild, A. J., & Fritz, M. S. (2007) · Annual Review of Psychology · doi:10.1146/annurev.psych.58.110405.085542 · Cited by 5,688
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Self-citationBariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Aminian, A., Brethauer, S. A., Navaneethan, S. D., Singh, R. P., Pothier, C. E., Nissen, S. E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1600869 · Cited by 2,934
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., Lau, D. C. W., le Roux, C. W., Violante Ortiz, R., Jensen, C. B., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411892 · Cited by 2,724
Ghrelin enhances appetite and increases food intake in humans
Wren, A. M., Seal, L. J., Cohen, M. A., Brynes, A. E., Frost, G. S., Murphy, K. G., Dhillo, W. S., Ghatei, M. A., & Bloom, S. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8111 · Cited by 2,494
Bariatric Surgery and Long-term Cardiovascular Events
Sjöström, L., Peltonen, M., Jacobson, P., Sjöström, C. D., Karason, K., Wedel, H., Ahlin, S., Anveden, Å., Bengtsson, C., Bergmark, G., et al. (2012) · JAMA · doi:10.1001/jama.2011.1914 · Cited by 1,656
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
Flint, A., Raben, A., Astrup, A., & Holst, J. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci990 · Cited by 1,402
Self-citationPeterli, R., Wölnerhanssen, B. K., Peters, T., Vetter, D., Kröll, D., Borbély, Y., Schultes, B., Beglinger, C., Drewe, J., Schiesser, M., et al. (2018) · JAMA · doi:10.1001/jama.2017.20897 · Cited by 1,267
Salminen, P., Helmiö, M., Ovaska, J., Juuti, A., Leivonen, M., Peromaa-Haavisto, P., Hurme, S., Soinio, M., Nuutila, P., & Victorzon, M. (2018) · JAMA · doi:10.1001/jama.2017.20313 · Cited by 946
le Roux, C. W., Astrup, A., Fujioka, K., Greenway, F., Lau, D. C. W., Van Gaal, L., Ortiz, R. V., Wilding, J. P. H., Skjøth, T. V., Manning, L. S., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30069-7 · Cited by 850
O'Neil, P. M., Birkenfeld, A. L., McGowan, B., Mosenzon, O., Pedersen, S. D., Wharton, S., Carson, C. G., Jepsen, C. H., Kabisch, M., & Wilding, J. P. H. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31773-2 · Cited by 814
Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass
le Roux, C. W., Welbourn, R., Werling, M., Osborne, A., Kokkinos, A., Laurenius, A., Lönroth, H., Fändriks, L., Ghatei, M. A., Bloom, S. R., et al. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e3180caa3e3 · Cited by 741
Subcutaneous Oxyntomodulin Reduces Body Weight in Overweight and Obese Subjects
Wynne, K., Park, A. J., Small, C. J., Patterson, M., Ellis, S. M., Murphy, K. G., Wren, A. M., Frost, G. S., Meeran, K., Ghatei, M. A., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2390 · Cited by 435
Peptide YY3–36 and Glucagon-Like Peptide-17–36 Inhibit Food Intake Additively
Neary, N. M., Small, C. J., Druce, M. R., Park, A. J., Ellis, S. M., Semjonous, N. M., Dakin, C. L., Filipsson, K., Wang, F., Kent, A. S., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0237 · Cited by 371
Wynne, K., Park, A. J., Small, C. J., Meeran, K., Ghatei, M. A., Frost, G. S., & Bloom, S. R. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803344 · Cited by 363
De Silva, A., Salem, V., Long, C. J., Makwana, A., Newbould, R. D., Rabiner, E. A., Ghatei, M. A., Bloom, S. R., Matthews, P. M., Beaver, J. D., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.09.010 · Cited by 353
Olbers, T., Bj??rkman, S., Lindroos, A., Maleckas, A., L??nn, L., Sj??str??m, L., & L??nroth, H. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000218085.25902.f8 · Cited by 340
Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig
Deacon, C. F., Pridal, L., Klarskov, L., Olesen, M., & Holst, J. J. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.271.3.e458 · Cited by 299
Self-citationNannipieri, M., Baldi, S., Mari, A., Colligiani, D., Guarino, D., Camastra, S., Barsotti, E., Berta, R., Moriconi, D., Bellini, R., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2538 · Cited by 293
Yousseif, A., Emmanuel, J., Karra, E., Millet, Q., Elkalaawy, M., Jenkinson, A. D., Hashemi, M., Adamo, M., Finer, N., Fiennes, A. G., et al. (2014) · Obesity Surgery · doi:10.1007/s11695-013-1066-0 · Cited by 259
Gastric bypass reduces fat intake and preference
le Roux, C. W., Bueter, M., Theis, N., Werling, M., Ashrafian, H., Löwenstein, C., Athanasiou, T., Bloom, S. R., Spector, A. C., Olbers, T., et al. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00139.2011 · Cited by 240
Shoar, S., & Saber, A. A. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.08.011 · Cited by 235
Hofsø, D., Fatima, F., Borgeraas, H., Birkeland, K. I., Gulseth, H. L., Hertel, J. K., Johnson, L. K., Lindberg, M., Nordstrand, N., Cvancarova Småstuen, M., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30344-4 · Cited by 201
Svane, M. S., Jørgensen, N. B., Bojsen-Møller, K. N., Dirksen, C., Nielsen, S., Kristiansen, V. B., Toräng, S., Wewer Albrechtsen, N. J., Rehfeld, J. F., Hartmann, B., et al. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.121 · Cited by 185
Self-citationChanges in Eating Behaviour and Meal Pattern Following Roux-En-Y Gastric Bypass
Laurenius, A., Larsson, I., Bueter, M., Melanson, K. J., Bosaeus, I., Forslund, H. B., Lönroth, H., Fändriks, L., & Olbers, T. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.217 · Cited by 174
Kadouh, H., Chedid, V., Halawi, H., Burton, D. D., Clark, M. M., Khemani, D., Vella, A., Acosta, A., & Camilleri, M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz140 · Cited by 166
Romero, F., Nicolau, J., Flores, L., Casamitjana, R., Ibarzabal, A., Lacy, A., & Vidal, J. (2012) · Surgical Endoscopy · doi:10.1007/s00464-012-2166-y · Cited by 165
Svane, M. S., Bojsen-Møller, K. N., Martinussen, C., Dirksen, C., Madsen, J. L., Reitelseder, S., Holm, L., Rehfeld, J. F., Kristiansen, V. B., van Hall, G., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.262 · Cited by 151
Self-citationEffects of PYY3–36 and GLP-1 on energy intake, energy expenditure, and appetite in overweight men
Schmidt, J. B., Gregersen, N. T., Pedersen, S. D., Arentoft, J. L., Ritz, C., Schwartz, T. W., Holst, J. J., Astrup, A., & Sjödin, A. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00569.2013 · Cited by 146
Self-citationUllrich, J., Ernst, B., Wilms, B., Thurnheer, M., & Schultes, B. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0754-5 · Cited by 135
SCHJOLDAGER, B. T. G., BALDISSERA, F. G. A., MORTENSEN, P. E., HOLST, J. J., & CHRISTIANSEN, J. (1988) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1988.tb01046.x · Cited by 134
Self-citationGoldstone, A. P., Miras, A. D., Scholtz, S., Jackson, S., Neff, K. J., Pénicaud, L., Geoghegan, J., Chhina, N., Durighel, G., Bell, J. D., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2665 · Cited by 121
Field, B. C. T., Wren, A. M., Peters, V., Baynes, K. C. R., Martin, N. M., Patterson, M., Alsaraf, S., Amber, V., Wynne, K., Ghatei, M. A., et al. (2010) · Diabetes · doi:10.2337/db09-1859 · Cited by 112
Food Intake and Changes in Eating Behavior After Laparoscopic Sleeve Gastrectomy
Coluzzi, I., Raparelli, L., Guarnacci, L., Paone, E., GENIO, G. D., le Roux, C. W., & Silecchia, G. (2016) · Obesity Surgery · doi:10.1007/s11695-015-2043-6 · Cited by 110
Giusti, V., Theytaz, F., Vetta, V. D., Clarisse, M., Suter, M., & Tappy, L. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.111732 · Cited by 107
Decreased energy density and changes in food selection following Roux-en-Y gastric bypass
Laurenius, A., Larsson, I., Melanson, K. J., Lindroos, A. K., Lönroth, H., Bosaeus, I., & Olbers, T. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.208 · Cited by 100
Perakakis, N., Kokkinos, A., Peradze, N., Tentolouris, N., Ghaly, W., Pilitsi, E., Upadhyay, J., Alexandrou, A., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2019.153997 · Cited by 93
Bagger, J. I., Holst, J. J., Hartmann, B., Andersen, B., Knop, F. K., & Vilsbøll, T. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2335 · Cited by 88
Self-citationTan, T., Behary, P., Tharakan, G., Minnion, J., Al-Najim, W., Albrechtsen, N. J. W., Holst, J. J., & Bloom, S. R. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00469 · Cited by 88
Self-citationAlamuddin, N., Vetter, M. L., Ahima, R. S., Hesson, L. A., Ritter, S., Minnick, A. M., Faulconbridge, L. F., Allison, K. C., Sarwer, D. B., Chittams, J. L., et al. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2505-5 · Cited by 85
Søndergaard Nielsen, M., Rasmussen, S., Just Christensen, B., Ritz, C., le Roux, C. W., Berg Schmidt, J., & Sjödin, A. (2018) · Obesity · doi:10.1002/oby.22272 · Cited by 83
Self-citationNielsen, M. S., Christensen, B., Ritz, C., Rasmussen, S., Hansen, T. T., Bredie, W. L. P., le Roux, C. W., Sjödin, A. M., & Schmidt, J. B. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2678-6 · Cited by 79
Self-citationCasajoana, A., Pujol, J., de Gordejuela, A. G. R., Elvira, J., Virgili, N. M., de Oca, F. J., Durán, X., Fernández‐Veledo, S., Vendrell, J. J., & Vilarrasa, N. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2669-7 · Cited by 78
Degradation Of Bioactive Substances: Physiology And Pathophysiology
Henriksen, J. H. (2024) · Degradation of Bioactive Substances · doi:10.1201/9781003574910-1 · Cited by 71
Wewer Albrechtsen, N. J., Hornburg, D., Albrechtsen, R., Svendsen, B., Toräng, S., Jepsen, S. L., Kuhre, R. E., Hansen, M., Janus, C., Floyd, A., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.03.034 · Cited by 69
Self-citationIn vivo and in vitro degradation of peptide YY3–36 to inactive peptide YY3–34 in humans
Toräng, S., Bojsen-Møller, K. N., Svane, M. S., Hartmann, B., Rosenkilde, M. M., Madsbad, S., & Holst, J. J. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00394.2015 · Cited by 61
Self-citationEFFECTS OF SOMATOSTATIN ANALOGUE SMS 201–995 IN NORMAL MAN
DAVIES, R. R., Miller, M. A., Turner, S. J., Goodship, T. H. J., Cook, D. B., WATSON, M., McGill, A. E., Ørskov, H., Alberti, K. G. M. M., & Johnston, D. G. (1986) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1986.tb01663.x · Cited by 60
ten Kulve, J. S., Veltman, D. J., Gerdes, V. E. A., van Bloemendaal, L., Barkhof, F., Deacon, C. F., Holst, J. J., Drent, M. L., Diamant, M., & IJzerman, R. G. (2017) · Diabetes Care · doi:10.2337/dc16-2113 · Cited by 55
Self-citationWallenius, V., Dirinck, E., Fändriks, L., Maleckas, A., le Roux, C. W., & Thorell, A. (2018) · Obesity Surgery · doi:10.1007/s11695-017-3061-3 · Cited by 55
Oxyntomodulin analogue increases energy expenditure via the glucagon receptor
Scott, R., Minnion, J., Tan, T., & Bloom, S. R. (2018) · Peptides · doi:10.1016/j.peptides.2018.04.008 · Cited by 48
Insights on glicentin, a promising peptide of the proglucagon family
Raffort, J., Lareyre, F., Massalou, D., Fénichel, P., Panaïa-Ferrari, P., & Chinetti, G. (2017) · Biochemia Medica · doi:10.11613/bm.2017.034 · Cited by 47
Cracking the combination: Gut hormones for the treatment of obesity and diabetes
Alexiadou, K., Anyiam, O., & Tan, T. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12664 · Cited by 34
Dischinger, U., Corteville, C., Otto, C., Fassnacht, M., Seyfried, F., & Hankir, M. K. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.04.008 · Cited by 26
Christensen, B., Schmidt, J. B., Nielsen, M. S., Tækker, L., Holm, L., Lunn, S., Bredie, W. L. P., Ritz, C., Holst, J. J., Hansen, T. F., et al. (2018) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2018.02.002 · Cited by 22
Self-citationBariatric Surgery Enhances Splanchnic Vascular Responses in Patients With Type 2 Diabetes
Honka, H., Koffert, J., Kauhanen, S. P., Teuho, J., Hurme, S. A. M., Mari, A., Lindqvist, A., Wierup, N., Groop, L., & Nuutila, P. (2017) · Diabetes · doi:10.2337/db16-0762 · Cited by 20
Cited by
Mechanisms of Weight Loss After Obesity Surgery
Akalestou, E., Miras, A. D., Rutter, G. A., & le Roux, C. W. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab022 · Cited by 136
Actions of glucagon‐like peptide‐1 receptor ligands in the gut
Holst, J. J., Andersen, D. B., & Grunddal, K. V. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15611 · Cited by 73
Self-citationProglucagon-Derived Peptides as Therapeutics
Lafferty, R. A., O’Harte, F. P. M., Irwin, N., Gault, V. A., & Flatt, P. R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.689678 · Cited by 71
Theilade, S., Christensen, M., Vilsbøll, T., & Knop, F. K. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14270 · Cited by 82
Do Gut Hormones Contribute to Weight Loss and Glycaemic Outcomes after Bariatric Surgery?
Papamargaritis, D., & le Roux, C. W. (2021) · Nutrients · doi:10.3390/nu13030762 · Cited by 68
“Limited data is also available on the changes of glicentin levels after bariatric surgery [23,33,97], however postprandial glicentin levels appear to be elevated after RYGB (Table 1).”
BackgroundInfluential
Metadata
- Authors
- Nielsen, M. S., Ritz, C., Wewer Albrechtsen, N. J., Holst, J. J., le Roux, C. W., & Sjödin, A.
- Affiliations
- University of Copenhagen (DK)
- Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- Investigative Science, Imperial College London, London, UK
- Corresponding author
- Nielsen, Mette S
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2020-02-04
- Volume
- 105
- Issue
- 4
- Pages
- e1064-e1074
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W3004650835
- Cited by
- 65
- References
- 58
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 11 · 2023: 8 · 2022: 11 · 2021: 17 · 2020: 3
- FWCI
- 8.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- University of Copenhagen Excellence Program for Interdisciplinary Research
- Novo Nordisk Foundation
- Lundbeck Foundation
- Aase and Ejnar Danielsens Foundation
- European Research Council (695069)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Keywords
- oxyntomodulin, glicentin, bariatric surgery, Roux-en-Y gastric bypass, sleeve gastrectomy, morbid obesity, weight loss, food preferences, energy density, energy intake, glucagon-like peptide-1, peptide YY, ghrelin, appetite regulation
- MeSH terms
- Adult, Energy Intake, Female, Follow-Up Studies, Food Preferences, Gastrectomy, Humans, Male, Obesity, Prognosis, Gastric Bypass, Biomarkers, Weight Loss, Case-Control Studies, Peptide YY, Bariatric Surgery, Glicentin, Oxyntomodulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.